Children with high-threshold peanut allergies may have a new path toward desensitization through a simple and inexpensive method. A recent study suggests that gradually increasing daily doses of store ...

The NIH has announced it will cap funds for “indirect costs” to grant recipients such as universities and hospitals.

The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Doctors at the UVM Medical Center are urging parents and guardians to get Respiratory syncytial virus (RSV) immunizations for ...

Influenza A virus particles strategically modify their shape becoming either spheres or larger filaments to enhance their ...

NIH trial informs potential treatment strategy for kids who already tolerate half a peanut or more. 11, 2025 – Eating ...

Children with high-threshold peanut allergies showed incredible improvements after undergoing an 18-month program using store ...

Influenza A virus particles strategically adapt their shape -- to become either spheres or larger filaments -- to favor their ability to infect cells depending on environmental conditions, according ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...